Ticker Details
Mineralys Therapeutics, Inc.
IPO Date:	February 10, 2023
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$2.27B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.55 | 3.24%
Avg Daily Range (30 D):	$0.55 | 2.02%
Avg Daily Range (90 D):	$0.72 | 2.65%

Institutional Daily Volume
Avg Daily Volume:	.56M
Avg Daily Volume (30 D):	.56M
Avg Daily Volume (90 D):	1.05M

Trade Size
Avg Trade Size (Sh.):	67
Avg Trade Size (Sh.) (30 D):	51
Avg Trade Size (Sh.) (90 D):	69

Institutional Trades
Total Institutional Trades:	1,135
Avg Institutional Trade:	$2.55M
Avg Institutional Trade (30 D):	$2.53M
Avg Institutional Trade (90 D):	$2.88M
Avg Institutional Trade Volume:	.1M
Avg Institutional Trades (Per Day):	2

Market Closing Trades
Avg Closing Trade:	$4.37M
Avg Closing Trade (30 D):	$3.23M
Avg Closing Trade (90 D):	$5M
Avg Closing Volume:	167.47K

News

Jun 8, 2026 @ 11:00 AM Mineralys Therapeutics to Present Late-Breaking Da... Source: Na

Jun 3, 2026 @ 10:00 AM Mineralys Therapeutics Announces Repurchase of Roy... Source: Na

May 31, 2026 @ 2:19 PM Velan Capital Drops 140,000 Mineralys Therapeutics... Source: Cory Renauer

May 30, 2026 @ 3:15 PM Mineralys Therapeutics Presents New Data from the ... Source: Mineralys Therapeutics

Nov 7, 2025 @ 11:10 PM Data for Lorundrostat in Chronic Kidney Disease an... Source: Mineralys Therapeutics

Financials
	TTM	Q2 2026	Q1 2026
Basic EPS	$-4.19	$-2.85	$-.47
Diluted EPS	$-4.19	$-2.85	$-.47
Revenue	$M	$M	$M
Gross Profit
Net Income / Loss	$-349.58M	$-241.07M	$-39.34M
Operating Income / Loss	$-370.79M	$-246.04M	$-45.34M
Cost of Revenue
Net Cash Flow	$36.48M	$25.49M	$-60.14M
PE Ratio